Because it supports collagen remodeling, the benefits tend to look natural: your skin, just more refined
Oct 23: Ulcerative colitis (UC) and Crohns disease (CD) patients who have previously used intravenous infliximab now have a subcutaneous option after the FDA approved Celltrions Zymfentra on Monday
Developed by Eli Lilly, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from currently approved therapies such as semaglutide and tirzepatide
Bradys appointment reflects a broader strategy: GLP-1 therapy is increasingly framed not only as treatment but as part of mainstream wellness and longevity conversations, a narrative that resonates in corporate leadership circles
Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S, et al
Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps